Surface Oncology Inc (SURF)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2023-08-11 | 2023-08-01 | V Vente |
Chief Executive Officer Dirigeant |
16 713
-16.7%
0,9415 710 USD |
16 713 -16.7% | 0,94 | 15 710 USD | |
| 2023-08-11 | 2023-08-01 | V Vente |
Deputy GC Dirigeant |
3 901
-11.2%
0,943 667 USD |
3 901 -11.2% | 0,94 | 3 667 USD | |
| 2023-08-11 | 2023-08-01 | V Vente |
Chief Medical Officer Dirigeant |
7 042
-11.1%
0,946 619 USD |
7 042 -11.1% | 0,94 | 6 619 USD | |
| 2023-08-11 | 2023-08-01 | V Vente |
Chief Financial Officer Dirigeant |
9 434
-8.5%
0,948 868 USD |
9 434 -8.5% | 0,94 | 8 868 USD | |
| 2022-08-05 | 2022-08-03 | V Vente |
Chief Scientific Officer Dirigeant |
4 463
-4.9%
1,727 676 USD |
4 463 -4.9% | 1,72 | 7 676 USD | |
| 2022-08-05 | 2022-08-03 | V Vente |
Chief Financial Officer Dirigeant |
5 980
-5.1%
1,7210 286 USD |
5 980 -5.1% | 1,72 | 10 286 USD | |
| 2022-08-05 | 2022-08-03 | V Vente |
Chief Medical Officer Dirigeant |
4 463
-6.5%
1,727 676 USD |
4 463 -6.5% | 1,72 | 7 676 USD | |
| 2022-08-05 | 2022-08-03 | V Vente |
Chief Executive Officer Dirigeant |
10 594
-9.6%
1,7218 222 USD |
10 594 -9.6% | 1,72 | 18 222 USD | |
| 2022-08-05 | 2022-08-03 | V Vente |
Chief Business Officer Dirigeant |
5 676
-14.9%
1,729 763 USD |
5 676 -14.9% | 1,72 | 9 763 USD | |
| 2022-01-14 | 2021-07-21 | V Vente |
Chief Medical Officer Dirigeant |
14 809
-32.9%
6,1090 335 USD |
14 809 -32.9% | 6,10 | 90 335 USD | |
| 2022-01-14 | 2021-07-21 | V Vente |
Chief Scientific Officer Dirigeant |
26 325
-32.9%
6,10160 583 USD |
26 325 -32.9% | 6,10 | 160 583 USD | |
| 2022-01-14 | 2021-07-21 | V Vente |
Chief Executive Officer Dirigeant |
33 500
-38.1%
6,10204 350 USD |
33 500 -38.1% | 6,10 | 204 350 USD | |
| 2022-01-14 | 2021-07-21 | V Vente | Administrateur non-exécutif |
127 778
-49.7%
6,10779 446 USD |
127 778 -49.7% | 6,10 | 779 446 USD | |
| 2022-01-14 | 2021-07-21 | V Vente |
Chief Financial Officer Dirigeant |
19 854
-20.0%
6,10121 109 USD |
19 854 -20.0% | 6,10 | 121 109 USD | |
| 2022-01-14 | 2021-07-21 | V Vente |
Chief Legal Officer Dirigeant |
26 325
-32.9%
6,10160 583 USD |
26 325 -32.9% | 6,10 | 160 583 USD | |
| 2021-06-11 | 2021-06-11 | V Vente | Administrateur non-exécutif |
15 273
-5.6%
7,61116 226 USD |
15 273 -5.6% | 7,61 | 116 226 USD | |
| 2021-06-11 | 2021-06-10 | V Vente | Administrateur non-exécutif |
234 727
-47.3%
7,661 798 619 USD |
234 727 -47.3% | 7,66 | 1 798 619 USD | |
| 2021-02-18 | 2021-02-16 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 000
-1.1%
11,3511 350 USD |
1 000 -1.1% | 11,35 | 11 350 USD | |
| 2021-02-09 | 2021-02-08 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
2 500
-0.9%
12,5031 250 USD |
2 500 -0.9% | 12,50 | 31 250 USD | |
| 2021-02-09 | 2021-02-08 | VP Vente planifiée |
See Remarks Dirigeant |
1 500
-1.5%
12,4518 675 USD |
1 500 -1.5% | 12,45 | 18 675 USD | |
| 2021-02-03 | 2021-02-01 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
2 500
-0.9%
10,6926 718 USD |
2 500 -0.9% | 10,69 | 26 718 USD | |
| 2021-02-03 | 2021-02-01 | VP Vente planifiée |
See Remarks Dirigeant |
1 500
-1.5%
11,1916 785 USD |
1 500 -1.5% | 11,19 | 16 785 USD | |
| 2021-01-21 | 2021-01-19 | VP Vente planifiée |
Chief Executive Officer Administrateur exécutif |
5 000
-1.9%
13,0065 000 USD |
5 000 -1.9% | 13,00 | 65 000 USD | |
| 2021-01-15 | 2021-01-15 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
2 000
-2.2%
12,2524 500 USD |
2 000 -2.2% | 12,25 | 24 500 USD | |
| 2021-01-15 | 2021-01-14 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
7 000
-7.1%
11,9583 650 USD |
7 000 -7.1% | 11,95 | 83 650 USD | |
| 2020-12-21 | 2020-12-17 | V Vente | Administrateur non-exécutif |
1 700 000
-36.6%
18,1030 770 000 USD |
1 700 000 -36.6% | 18,10 | 30 770 000 USD | |
| 2020-12-21 | 2020-12-17 | V Vente | Actionnaire important |
1 700 000
-36.6%
18,1030 770 000 USD |
1 700 000 -36.6% | 18,10 | 30 770 000 USD | |
| 2020-12-17 | 2020-12-15 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 000
-1.0%
10,4810 480 USD |
1 000 -1.0% | 10,48 | 10 480 USD | |
| 2020-12-15 | 2020-12-11 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
1 405
-1.4%
10,0514 120 USD |
1 405 -1.4% | 10,05 | 14 120 USD | |
| 2020-11-13 | 2020-11-11 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
595
-0.6%
10,055 980 USD |
595 -0.6% | 10,05 | 5 980 USD | |
| 2020-10-16 | 2020-10-14 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
4 000
-3.8%
10,0540 200 USD |
4 000 -3.8% | 10,05 | 40 200 USD | |
| 2020-09-03 | 2020-09-01 | V Vente | Actionnaire important |
332 780
-6.6%
7,142 376 681 USD |
332 780 -6.6% | 7,14 | 2 376 681 USD | |
| 2020-05-22 | 2020-05-20 | V Vente |
New Enterprise Associates 14, L.P. Actionnaire important |
420 000
-12.7%
3,661 535 562 USD |
420 000 -12.7% | 3,66 | 1 535 562 USD | |
| 2020-02-07 | 2020-02-05 | A Achat |
Chief Executive Officer Administrateur exécutif |
5 000
+1.9%
3,2316 150 USD |
5 000 +1.9% | 3,23 | 16 150 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
Atlas Venture Fund IX, L.P. Actionnaire important |
100 000
+2.2%
15,001 500 000 USD |
100 000 +2.2% | 15,00 | 1 500 000 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
Viswanathan Ravi Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
Sonsini Peter W. Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
Florence Anthony A. Jr. Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
GRAYZEL DAVID S. Administrateur non-exécutif |
100 000
+2.2%
15,001 500 000 USD |
100 000 +2.2% | 15,00 | 1 500 000 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
New Enterprise Associates 14, L.P. Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
LV Management Group, LLC Actionnaire important |
266 000
+8.4%
15,003 990 000 USD |
266 000 +8.4% | 15,00 | 3 990 000 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
Shanafelt Armen Administrateur non-exécutif Actionnaire important |
266 000
+8.4%
15,003 990 000 USD |
266 000 +8.4% | 15,00 | 3 990 000 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
BARRIS PETER J Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
BARRETT M JAMES Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
Novartis Institutes for BioMedical Research, Inc. Actionnaire important |
766 666
+24.1%
15,0011 499 990 USD |
766 666 +24.1% | 15,00 | 11 499 990 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
KERINS PATRICK J Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
SANDELL SCOTT D Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
MOTT DAVID M Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD | |
| 2018-04-23 | 2018-04-23 | A Achat |
BASKETT FOREST Actionnaire important |
133 333
+4.2%
15,001 999 995 USD |
133 333 +4.2% | 15,00 | 1 999 995 USD |